A detailed history of Sectoral Asset Management Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 11,010 shares of EXEL stock, worth $392,066. This represents 0.24% of its overall portfolio holdings.

Number of Shares
11,010
Previous 11,460 3.93%
Holding current value
$392,066
Previous $257,000 10.89%
% of portfolio
0.24%
Previous 0.13%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.96 - $27.6 $9,882 - $12,420
-450 Reduced 3.93%
11,010 $285,000
Q2 2024

Aug 13, 2024

SELL
$20.34 - $23.73 $34,171 - $39,866
-1,680 Reduced 12.79%
11,460 $257,000
Q1 2024

May 14, 2024

SELL
$20.17 - $23.93 $17,144 - $20,340
-850 Reduced 6.08%
13,140 $311,000
Q4 2023

Feb 14, 2024

BUY
$19.25 - $24.13 $29,067 - $36,436
1,510 Added 12.1%
13,990 $335,000
Q3 2023

Nov 14, 2023

BUY
$19.04 - $22.74 $237,619 - $283,795
12,480 New
12,480 $272,000
Q4 2022

Feb 10, 2023

BUY
$14.96 - $17.39 $1,496 - $1,739
100 Added 0.02%
553,475 $8.88 Million
Q3 2022

Nov 10, 2022

BUY
$15.68 - $22.27 $2.67 Million - $3.79 Million
170,350 Added 44.47%
553,375 $8.68 Million
Q2 2022

Aug 15, 2022

BUY
$17.44 - $23.16 $334,586 - $444,324
19,185 Added 5.27%
383,025 $7.98 Million
Q1 2022

May 10, 2022

SELL
$17.03 - $22.67 $785,083 - $1.05 Million
-46,100 Reduced 11.25%
363,840 $8.25 Million
Q4 2021

Feb 11, 2022

BUY
$15.84 - $21.88 $420,868 - $581,351
26,570 Added 6.93%
409,940 $7.49 Million
Q3 2021

Nov 15, 2021

SELL
$16.3 - $21.14 $570,500 - $739,900
-35,000 Reduced 8.37%
383,370 $8.1 Million
Q2 2021

Aug 16, 2021

SELL
$17.95 - $25.56 $1.29 Million - $1.83 Million
-71,688 Reduced 14.63%
418,370 $7.62 Million
Q1 2021

May 14, 2021

SELL
$20.53 - $25.22 $26.9 Million - $33.1 Million
-1,312,212 Reduced 72.81%
490,058 $11.1 Million
Q4 2020

Feb 12, 2021

BUY
$18.39 - $24.8 $17.4 Million - $23.4 Million
945,500 Added 110.36%
1,802,270 $36.2 Million
Q3 2020

Nov 13, 2020

SELL
$20.67 - $26.94 $2.08 Million - $2.71 Million
-100,624 Reduced 10.51%
856,770 $20.9 Million
Q2 2020

Aug 13, 2020

BUY
$16.46 - $27.42 $4.1 Million - $6.84 Million
249,304 Added 35.21%
957,394 $22.7 Million
Q1 2020

May 13, 2020

BUY
$14.46 - $21.8 $10.2 Million - $15.4 Million
708,090 New
708,090 $12.2 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.